REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 64 filers reported holding REGENXBIO INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $734,577 | +164.4% | 44,628 | +264.3% | 0.00% | – |
| Q4 2022 | $277,807 | -36.1% | 12,249 | -25.5% | 0.00% | -100.0% |
| Q3 2022 | $435,000 | -82.8% | 16,449 | -72.7% | 0.00% | -50.0% |
| Q3 2021 | $2,528,000 | -75.1% | 60,303 | -77.0% | 0.00% | -77.8% |
| Q2 2021 | $10,170,000 | +16.4% | 261,770 | +2.2% | 0.01% | +12.5% |
| Q1 2021 | $8,739,000 | +32.5% | 256,225 | +76.2% | 0.01% | +33.3% |
| Q4 2020 | $6,595,000 | +76.9% | 145,387 | +7.3% | 0.01% | +50.0% |
| Q3 2020 | $3,729,000 | -5.5% | 135,479 | +26.5% | 0.00% | -20.0% |
| Q2 2020 | $3,944,000 | +32.2% | 107,081 | +16.2% | 0.01% | 0.0% |
| Q1 2020 | $2,984,000 | +206.7% | 92,163 | +287.9% | 0.01% | +400.0% |
| Q4 2019 | $973,000 | -22.5% | 23,761 | -32.6% | 0.00% | -50.0% |
| Q3 2019 | $1,256,000 | -44.9% | 35,275 | -20.6% | 0.00% | -33.3% |
| Q2 2019 | $2,281,000 | +626.4% | 44,400 | +366.6% | 0.00% | – |
| Q3 2017 | $314,000 | -36.7% | 9,516 | -68.2% | 0.00% | -100.0% |
| Q4 2015 | $496,000 | – | 29,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |